Mary L. Stagnitto

Biological profile of the metabolites and potential metabolites of the anticonvulsant remacemide

Gene C. Palmer, Robert Murray, Theresa C. Wilson et al. · Epilepsy Research · 1992 · 81 citations

Medicine, Physiology, Biological Profile +9

Kainic acid and 4-aminopyridine seizure models in mice: Evaluation of efficacy of anti-epileptic agents and calcium antagonists

Carrie L. Cramer, Mary L. Stagnitto, Marilyn A. Knowles et al. · Life Sciences · 1994 · 67 citations

Neuromodulation (Medicine), Neurophysiology, Medicine +12

Anticonvulsant Properties of Calcium Channel Blockers in Mice: <i>N</i>‐Methyl‐D‐, L‐Aspartate‐ and Bay K 8644‐Induced Convulsions are Potently Blocked by the Dihydropyridines

Gene C. Palmer, Mary L. Stagnitto, Ranjit Ray et al. · Epilepsia · 1993 · 56 citations

Preclinical profile of remacemide: A novel anticonvulsant effective against maximal electroshock seizures in mice

Mary L. Stagnitto, Gene C. Palmer, J. M. Ordy et al. · Epilepsy Research · 1990 · 37 citations

Neuromodulation (Medicine), Neurophysiology, Medicine +10

[(S)-Alpha-Phenyl-2-Pyridine-Ethanamine Dihydrochloride], A Low Affinity Uncompetitive N-Methyl-d-Aspartic Acid Antagonist, Is Effective in Rodent Models of Global and Focal Ischemia

EDWARD F. CREGAN, James Peeling, Dale Corbett et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 36 citations